The appropriate use of proton-pump inhibitor co-therapy with non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors
- 1 March 2005
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 21 (s1) , 2-4
- https://doi.org/10.1111/j.1365-2036.2004.02341.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Guidelines for the appropriate use of non‐steroidal anti‐inflammatory drugs, cyclo‐oxygenase‐2‐specific inhibitors and proton pump inhibitors in patients requiring chronic anti‐inflammatory therapyAlimentary Pharmacology & Therapeutics, 2004
- CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rateGastroenterology, 2003
- Ulcer Prevention in Long-term Users of Nonsteroidal Anti-inflammatory DrugsArchives of internal medicine (1960), 2002
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Nitrovasodilators, Low-Dose Aspirin, Other Nonsteroidal Antiinflammatory Drugs, and the Risk of Upper Gastrointestinal BleedingNew England Journal of Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Risk of upper gastrointestinal bleeding associated with use of low-dose aspirinAmerican Journal of Gastroenterology, 2000
- Association Between Nonsteroidal Anti-inflammatory Drugs and Upper Gastrointestinal Tract Bleeding/PerforationArchives of internal medicine (1960), 2000
- Prophylactic aspirin and risk of peptic ulcer bleedingBMJ, 1995
- Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory DrugsAnnals of Internal Medicine, 1991